List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glucagon Revenue
1.4 Market Analysis by Type
1.4.1 Global Glucagon Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Inject Glucagon
1.4.3 Nasal Glucagon
1.5 Market by Application
1.5.1 Global Glucagon Market Share by Application: 2022-2027
1.5.2 Emergency Kits
1.5.3 General Use
1.5.4 Diagnostic & Motility
1.5.5 Cardiogenic Shock
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Glucagon Market
1.8.1 Global Glucagon Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Glucagon Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Glucagon Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Glucagon Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Glucagon Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Glucagon Sales Volume Market Share by Region (2016-2021)
3.2 Global Glucagon Sales Revenue Market Share by Region (2016-2021)
3.3 North America Glucagon Sales Volume
3.3.1 North America Glucagon Sales Volume Growth Rate (2016-2021)
3.3.2 North America Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Glucagon Sales Volume
3.4.1 East Asia Glucagon Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Glucagon Sales Volume (2016-2021)
3.5.1 Europe Glucagon Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Glucagon Sales Volume (2016-2021)
3.6.1 South Asia Glucagon Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Glucagon Sales Volume (2016-2021)
3.7.1 Southeast Asia Glucagon Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Glucagon Sales Volume (2016-2021)
3.8.1 Middle East Glucagon Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Glucagon Sales Volume (2016-2021)
3.9.1 Africa Glucagon Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Glucagon Sales Volume (2016-2021)
3.10.1 Oceania Glucagon Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Glucagon Sales Volume (2016-2021)
3.11.1 South America Glucagon Sales Volume Growth Rate (2016-2021)
3.11.2 South America Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Glucagon Sales Volume (2016-2021)
3.12.1 Rest of the World Glucagon Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Glucagon Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Glucagon Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Glucagon Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Glucagon Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Glucagon Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Glucagon Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Glucagon Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Glucagon Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Glucagon Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Glucagon Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Glucagon Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Glucagon Sales Volume Market Share by Type (2016-2021)
14.2 Global Glucagon Sales Revenue Market Share by Type (2016-2021)
14.3 Global Glucagon Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Glucagon Consumption Volume by Application (2016-2021)
15.2 Global Glucagon Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Glucagon Business
16.1 Novo Nordisk
16.1.1 Novo Nordisk Company Profile
16.1.2 Novo Nordisk Glucagon Product Specification
16.1.3 Novo Nordisk Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Eli Lilly
16.2.1 Eli Lilly Company Profile
16.2.2 Eli Lilly Glucagon Product Specification
16.2.3 Eli Lilly Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Fresenius Kabi
16.3.1 Fresenius Kabi Company Profile
16.3.2 Fresenius Kabi Glucagon Product Specification
16.3.3 Fresenius Kabi Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Torrent Labs
16.4.1 Torrent Labs Company Profile
16.4.2 Torrent Labs Glucagon Product Specification
16.4.3 Torrent Labs Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Taj Pharmaceuticals
16.5.1 Taj Pharmaceuticals Company Profile
16.5.2 Taj Pharmaceuticals Glucagon Product Specification
16.5.3 Taj Pharmaceuticals Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Xeris Pharmaceuticals
16.6.1 Xeris Pharmaceuticals Company Profile
16.6.2 Xeris Pharmaceuticals Glucagon Product Specification
16.6.3 Xeris Pharmaceuticals Glucagon Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Glucagon Manufacturing Cost Analysis
17.1 Glucagon Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Glucagon
17.4 Glucagon Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Glucagon Distributors List
18.3 Glucagon Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Glucagon (2022-2027)
20.2 Global Forecasted Revenue of Glucagon (2022-2027)
20.3 Global Forecasted Price of Glucagon (2016-2027)
20.4 Global Forecasted Production of Glucagon by Region (2022-2027)
20.4.1 North America Glucagon Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Glucagon Production, Revenue Forecast (2022-2027)
20.4.3 Europe Glucagon Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Glucagon Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Glucagon Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Glucagon Production, Revenue Forecast (2022-2027)
20.4.7 Africa Glucagon Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Glucagon Production, Revenue Forecast (2022-2027)
20.4.9 South America Glucagon Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Glucagon Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Glucagon by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Glucagon by Country
21.2 East Asia Market Forecasted Consumption of Glucagon by Country
21.3 Europe Market Forecasted Consumption of Glucagon by Countriy
21.4 South Asia Forecasted Consumption of Glucagon by Country
21.5 Southeast Asia Forecasted Consumption of Glucagon by Country
21.6 Middle East Forecasted Consumption of Glucagon by Country
21.7 Africa Forecasted Consumption of Glucagon by Country
21.8 Oceania Forecasted Consumption of Glucagon by Country
21.9 South America Forecasted Consumption of Glucagon by Country
21.10 Rest of the world Forecasted Consumption of Glucagon by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
